Latest Product Development News

Entyr Limited has ramped up tyre receivals and processing volumes in the December quarter, alongside securing new supply and offtake agreements as it prepares for ASX reinstatement. The company’s ongoing plant upgrades and strategic partnerships signal a potential turnaround in its operational and financial trajectory.

Energy Action Limited reported a positive net cash inflow from operating activities of $1.076 million for the December quarter, maintaining a solid cash position amid ongoing financing arrangements.

Cue Energy delivered a robust quarter with $4.3 million net cash flow and a $17.1 million cash balance, driven by strong drilling results and production growth across its Australian and Indonesian assets.

Nuchev Limited has reported its first positive operating cashflow quarter alongside a 65% increase in revenue for the first half of FY25, driven by strong sales growth and the bWellness acquisition.

ReNerve Limited has reported a remarkable 260% increase in quarterly sales following its successful IPO, alongside strategic distribution deals in Hong Kong and the Middle East. The company is poised for further growth with upcoming clinical data and product developments.

Alpha HPA Limited has reached a major funding milestone with a $400 million senior debt package for its HPA First Project Stage 2, while experiencing accelerating demand from the semiconductor sector and advancing new product developments.

BluGlass Limited has unveiled significant advances in gallium nitride (GaN) laser technology at SPIE Photonics West, filing three US provisional patents and demonstrating a powerful integrated laser amplifier. These developments position the company at the forefront of quantum, aerospace, and biotech photonics innovation.

Bio-Gene Technology Limited has been awarded two U.S. Department of Defense grants totaling A$3 million to develop innovative insect control products targeting military and civilian markets.

CurveBeam AI has reported a record quarter for HiRise™ device purchase orders, driven by a strategic expansion with Stryker in Australia and New Zealand. The company also advanced its FDA regulatory pathway for its BMD module, setting sights on mid-2025 submission.

4DMedical reports a remarkable 202% increase in Q2 FY2025 operating revenue, driven by rapid site expansion and key collaborations with leading healthcare providers and the U.S. Department of Defense.

Sarytogan Graphite Limited has secured a key mining license and demonstrated promising product applications, supported by a significant investment from the European Bank for Reconstruction and Development. The company is progressing towards customer qualification and offtake agreements while expanding exploration efforts.

RemSense Technologies delivered a cashflow positive Q2 FY2025, driven by a 78% surge in customer receipts and successful execution of major global contracts. The company’s virtualplant platform continues to gain traction across mining, oil and gas, and new industrial sectors.